PB:NYSEProsperity Bancshares, Inc. Analysis
Data as of 2026-08-27 - not real-time
$72.56
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Prosperity Bancshares, Inc. is priced at $72.56 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has lost 2.9%. Momentum indicators put RSI at 43.7 (neutral) with MACD reading bearish. Watch $72.01 as support and $75.87 as the nearer resistance level.
The shares look undervalued, trading on 12.6 times earnings below a sector average of 17.0. Analyst price targets sit 12.2% above the current price. Revenue is growing at 25.9% on a 40.4% profit margin. The 3.28% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 12.3%, a beta of 0.45 and a maximum drawdown of 15.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.
The shares look undervalued, trading on 12.6 times earnings below a sector average of 17.0. Analyst price targets sit 12.2% above the current price. Revenue is growing at 25.9% on a 40.4% profit margin. The 3.28% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 12.3%, a beta of 0.45 and a maximum drawdown of 15.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.
Top Market Events
In late July 2026, Prosperity Bancshares reported higher second-quarter and year-to-date earnings, continued modest net...Prosperity Bancshares earnings and acquisitions update Prosperity Bancshares PB has drawn investor attention after...Prosperity Bancshares PB delivered earnings and revenue surprises of +5.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 70.47
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 12.6 versus sector average of 17.0
- Trading above the 200-day average of 70.47
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 12.6 versus sector average of 17.0
- Analyst targets imply +12.2% versus the current price
- Profit margin of 40.4% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth25.90%
Profit Margin40.42%
P/E Ratio12.6
ROE7.07%
ROA1.37%
P/B Ratio0.9
Op. Cash Flow$620.7M
Industry P/E17.0
Technical Analysis
TrendBullish
RSI43.7
Support$72.01
Resistance$75.87
MA 20$73.84
MA 50$73.14
MA 200$70.47
MACDBearish
VolumeDecreasing
Fear & Greed Index95.43
Valuation
Fair Value$118.69
Target Price$81.38
Upside/Downside12.17%
GradeUndervalued
TypeValue
Dividend Yield3.28%
Risk Assessment
Beta0.45
Volatility12.27%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.